RISK OF EARLY AND LATE CARDIOTOXICITY IN DOXORUBICIN-TREATED BREAST-CANCER PATIENTS

被引：0
|
作者：
BUZDAR, A [1 ]
SMITH, T [1 ]
MARCUS, C [1 ]
BLUMENSCHEIN, G [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
BREAST CANCER RESEARCH AND TREATMENT | 1983年 / 3卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [41] Role of metabolomics in the identification of early patterns of cardiotoxicity in patients with breast cancer treated with anthracyclines
    Pinna, Gabriele
    Aneris, Federico
    Agus, Elena
    Demelas, Roberta
    Peccianti, Antonella
    Pettinau, Antonio
    Zanda, Greca
    Noto, Antonio
    Fattuoni, Claudia
    Deidda, Martino
    Atzori, Francesco
    Madeddu, Clelia
    Scartozzi, Mario
    Mercuro, Giuseppe
    Dessalvi, Christian Cadeddu
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N19 - N20
  • [42] Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients
    Maestrini, Viviana
    Cheang, Mun H.
    Kotwinski, Paul
    Rosmini, Stefania
    Lloyd, Guy
    Kellman, Peter
    Pennell, Dudley J.
    Montgomery, Hugh
    Moon, James C.
    Manisty, Charlotte
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (20) : 2573 - 2575
  • [43] EPIRUBICIN CARDIOTOXICITY - A STUDY OF 135 PATIENTS WITH ADVANCED BREAST-CANCER
    NIELSEN, D
    JENSEN, JB
    DOMBERNOWSKY, P
    MUNCK, O
    FOGH, J
    BRYNJOLF, I
    HAVSTEEN, H
    HANSEN, M
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (11) : 1806 - 1810
  • [44] Early Cardiac Function Monitoring for Detection of Subclinical Doxorubicin Cardiotoxicity in Young Adult Patients with Breast Cancer
    Chung, Woo-Baek
    Yi, Jeong-Eun
    Jin, Jung Yeon
    Choi, Yun-Seok
    Park, Chan Seok
    Park, Woo-Chan
    Song, Byung Joo
    Youn, Ho-Joong
    JOURNAL OF BREAST CANCER, 2013, 16 (02) : 178 - 183
  • [45] Liposomal doxorubicin significantly reduces cardiotoxicity in advanced breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (09): : 1135 - 1135
  • [46] Metabolic phenotypes of doxorubicin-induced cardiotoxicity in breast cancer patients
    Jun, Se-Ran
    Wallis, Katherine
    Landes, Reid D.
    Todorova, Valentina K.
    Su, L. Joseph
    Makhoul, Sam
    Hsu, Ping-Ching
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Pharmacogenetics of cardiotoxicity in the treatment of black Zimbabwean breast cancer patients on doxorubicin
    Nyangwara, Vincent Aketch
    Mazhindu, Tinashe
    Chikwambi, Zedias
    Masimirembwa, Collen
    Campbell, Thomas B.
    Borok, Margaret
    Ndlovu, Ntokozo
    PHARMACOGENETICS AND GENOMICS, 2023, 33 (08): : 203 - 204
  • [48] PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF DOBUTAMINE INFUSIONS IN DOXORUBICIN-TREATED PATIENTS
    BERG, RA
    PADBURY, JF
    KLEWER, SE
    DONNERSTEIN, RL
    HUTTER, JJ
    PEDIATRIC RESEARCH, 1991, 29 (04) : A57 - A57
  • [49] PHARMACOKINETICS OF EPI-DOXORUBICIN AND DOXORUBICIN IN BREAST-CANCER PATIENTS - A CROSSOVER STUDY
    MROSS, K
    MAESSEN, P
    VANDERVIJGH, WJF
    GALL, H
    BOVEN, E
    PINEDO, HM
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 114 - 114
  • [50] EARLY AND LATE BREAST-CANCER - UNIFIED CONCEPT FOR TREATMENT
    EDELSTYN, GA
    MACRAE, KD
    CLINICAL RADIOLOGY, 1976, 27 (04) : 455 - 462
12345